share_log

醫思健康：更換核數師

EC HEALTHCARE: Change in Auditor

香港交易所 ·  Mar 19 06:53
Summary by Moomoo AI
醫思健康（EC Healthcare）於2024年3月19日宣布更換核數師。由於無法與畢馬威會計師事務所就2024財年的核數費達成共識，畢馬威自同日起辭任。公司審核委員會經評估後，決定委任安永會計師事務所接替畢馬威，任期至下一屆股東週年大會結束。董事會表示，畢馬威辭任不會對公司年度審核及全年業績造成重大影響，並對畢馬威多年來的服務表示感謝。新任核數師安永被認為具備適當資格並符合委任條件。
醫思健康（EC Healthcare）於2024年3月19日宣布更換核數師。由於無法與畢馬威會計師事務所就2024財年的核數費達成共識，畢馬威自同日起辭任。公司審核委員會經評估後，決定委任安永會計師事務所接替畢馬威，任期至下一屆股東週年大會結束。董事會表示，畢馬威辭任不會對公司年度審核及全年業績造成重大影響，並對畢馬威多年來的服務表示感謝。新任核數師安永被認為具備適當資格並符合委任條件。
EC Healthcare announced the replacement of Auditors on 19 March 2024. As a result of the inability to reach an agreement with the Office of Accounting Firms on the audit fee for the financial year 2024, Bumway resigned on the same day. After evaluation, the Audit Committee of the Company decided to appoint EY Accounting Firm to replace Pimawy for a term of office until the end of the next Annual General Meeting. The Board of Directors stated that the resignation of BMW would not have a significant impact on the Company's annual audit and annual results and expressed its gratitude for the many years of service. The new auditor, EY, is deemed to be suitably qualified and eligible for appointment.
EC Healthcare announced the replacement of Auditors on 19 March 2024. As a result of the inability to reach an agreement with the Office of Accounting Firms on the audit fee for the financial year 2024, Bumway resigned on the same day. After evaluation, the Audit Committee of the Company decided to appoint EY Accounting Firm to replace Pimawy for a term of office until the end of the next Annual General Meeting. The Board of Directors stated that the resignation of BMW would not have a significant impact on the Company's annual audit and annual results and expressed its gratitude for the many years of service. The new auditor, EY, is deemed to be suitably qualified and eligible for appointment.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more